BRPI0912193A2 - compostos terapêuticos. - Google Patents
compostos terapêuticos.Info
- Publication number
- BRPI0912193A2 BRPI0912193A2 BRPI0912193A BRPI0912193A BRPI0912193A2 BR PI0912193 A2 BRPI0912193 A2 BR PI0912193A2 BR PI0912193 A BRPI0912193 A BR PI0912193A BR PI0912193 A BRPI0912193 A BR PI0912193A BR PI0912193 A2 BRPI0912193 A2 BR PI0912193A2
- Authority
- BR
- Brazil
- Prior art keywords
- therapeutic compounds
- therapeutic
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5175308P | 2008-05-09 | 2008-05-09 | |
PCT/US2009/042479 WO2009137345A1 (en) | 2008-05-09 | 2009-05-01 | Therapeutic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0912193A2 true BRPI0912193A2 (pt) | 2015-10-06 |
Family
ID=40846112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0912193A BRPI0912193A2 (pt) | 2008-05-09 | 2009-05-01 | compostos terapêuticos. |
Country Status (10)
Country | Link |
---|---|
US (1) | US7964599B2 (pt) |
EP (1) | EP2285790A1 (pt) |
JP (1) | JP2011519939A (pt) |
KR (1) | KR20110031423A (pt) |
CN (1) | CN102083807A (pt) |
AU (1) | AU2009244541B2 (pt) |
BR (1) | BRPI0912193A2 (pt) |
CA (1) | CA2724972A1 (pt) |
RU (1) | RU2500674C2 (pt) |
WO (1) | WO2009137345A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7732443B2 (en) * | 2008-03-18 | 2010-06-08 | Yariv Donde | Therapeutic substituted cyclopentanes |
US8530471B2 (en) * | 2008-05-09 | 2013-09-10 | Allergan, Inc. | Therapeutic cyclopentane derivatives |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4166452A (en) * | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US4675182A (en) * | 1983-02-12 | 1987-06-23 | Bayer Aktiengesellschaft | Complexes of prostaglandins |
US5288754A (en) * | 1992-02-04 | 1994-02-22 | Allergan, Inc. | Polar C-1 esters of prostaglandins |
US6437146B1 (en) * | 1998-09-25 | 2002-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compounds as prostaglandin e2 agonists or antagonists |
US6410591B1 (en) * | 2001-05-08 | 2002-06-25 | Allergan Sales, Inc. | 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
BR0213911A (pt) * | 2001-11-05 | 2004-09-28 | Allergan Inc | Análogos de Èmega-cicloalquil 17-heteroaril prostaglandina e2 como agonistas do receptor ep2 |
MXPA05008431A (es) * | 2003-02-11 | 2005-10-19 | Allergan Inc | Derivados de acido 10,10-dialquil prostanoico como agentes para reducir la presion intraocular. |
TWI348386B (en) * | 2003-08-12 | 2011-09-11 | R Tech Ueno Ltd | Composition and method for promoting hair growth |
US7091231B2 (en) | 2004-12-10 | 2006-08-15 | Allergan, Inc. | 12-Aryl prostaglandin analogs |
US7427685B2 (en) * | 2005-12-06 | 2008-09-23 | Allergan, Inc. | Therapeutic substituted cyclopentanes |
US7476755B2 (en) * | 2006-05-04 | 2009-01-13 | Allergan, Inc. | Therapeutic compounds |
-
2009
- 2009-05-01 BR BRPI0912193A patent/BRPI0912193A2/pt not_active IP Right Cessation
- 2009-05-01 RU RU2010149493/04A patent/RU2500674C2/ru active
- 2009-05-01 CN CN2009801262278A patent/CN102083807A/zh active Pending
- 2009-05-01 EP EP09743332A patent/EP2285790A1/en not_active Withdrawn
- 2009-05-01 CA CA2724972A patent/CA2724972A1/en not_active Abandoned
- 2009-05-01 AU AU2009244541A patent/AU2009244541B2/en not_active Ceased
- 2009-05-01 US US12/434,008 patent/US7964599B2/en active Active
- 2009-05-01 WO PCT/US2009/042479 patent/WO2009137345A1/en active Application Filing
- 2009-05-01 JP JP2011508563A patent/JP2011519939A/ja active Pending
- 2009-05-01 KR KR1020107027695A patent/KR20110031423A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2009244541B2 (en) | 2014-01-09 |
WO2009137345A1 (en) | 2009-11-12 |
US20090281104A1 (en) | 2009-11-12 |
KR20110031423A (ko) | 2011-03-28 |
RU2010149493A (ru) | 2012-06-20 |
US7964599B2 (en) | 2011-06-21 |
JP2011519939A (ja) | 2011-07-14 |
AU2009244541A1 (en) | 2009-11-12 |
CA2724972A1 (en) | 2009-11-12 |
RU2500674C2 (ru) | 2013-12-10 |
CN102083807A (zh) | 2011-06-01 |
EP2285790A1 (en) | 2011-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2021006I1 (no) | Quofenix, delafloksacin | |
DK2288375T3 (da) | Pegylerede insulin-lispro-forbindelser | |
BRPI0920707A2 (pt) | compostos | |
DK2242759T3 (da) | Forbindelser | |
BRPI0920428A2 (pt) | inalador. | |
SMT201600045B (it) | Composti tetraciclinici c7-fluoro sostituiti | |
BRPI0813500A2 (pt) | Compostos antivirais | |
BRPI0815717A2 (pt) | Compostos de imidazopirazina. | |
BRPI0821086A2 (pt) | Compostos inseticidas | |
BRPI1007310A2 (pt) | Compostos inseticidas. | |
BRPI0916931A2 (pt) | agentes terapêuticos | |
BRPI0811264A2 (pt) | Compostos | |
FIC20240018I1 (fi) | Vamoroloni | |
DK2297162T3 (da) | Forbindelser | |
BRPI1016190A2 (pt) | compostos farmacêuticos. | |
BRPI0814424A2 (pt) | Compostos heterociclila | |
DK2173831T3 (da) | Brøndbehandling | |
BRPI0916432A2 (pt) | compostos | |
BRPI0809996A2 (pt) | Compostos | |
BRPI0912716A2 (pt) | composto. | |
DK2271618T3 (da) | Farmaceutiske forbindelser | |
BRPI0820410A2 (pt) | Lactans substituídos terapêuticos | |
BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
BRPI0815181A2 (pt) | Compostos | |
DK2206698T3 (da) | Ethynylindolforbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |